Medicale Corp., a company focused on offering consulting services and distributing dietary supplements, has released its Form 10-Q report for the first quarter of 2024. The report provides insights into the company's financial performance and operational status, highlighting significant management changes, ongoing challenges, and future outlook.
Financial Highlights
- Net Loss: $11,564 for the three months ended March 31, 2024, compared to $6,115 for the same period in 2023, primarily due to increased general and administrative expenses.
- Net Loss for Six Months: $30,871 for the six months ended March 31, 2024, compared to $14,829 for the same period in 2023, reflecting higher operating expenses.
- Net Loss Per Share: $(0.00) from continuing operations for both three and six months ended March 31, 2024 and 2023, indicating no change in per-share loss despite increased net loss.
- Cash Flows Used in Operating Activities: $58,788 for the six months ended March 31, 2024, compared to $5,259 for the same period in 2023, driven by changes in accounts payable and related party advances.
- Cash Flows Provided by Financing Activities: $58,788 for the six months ended March 31, 2024, primarily from proceeds of a convertible note.
Business Highlights
- Company Overview: Medicale Corp. is focused on offering consulting services and distributing dietary supplements. The company was incorporated in Nevada on August 17, 2020, and is currently in the process of establishing its operations.
- Operational Status: As of the date of the report, Medicale Corp. has not commenced any significant operations. The company's activities have primarily been focused on preserving cash, raising capital, and maintaining public reporting obligations.
- Management Changes: On December 28, 2022, there was a significant change in the company's management and ownership. Borisi Alborovi, the previous majority shareholder, sold his shares to Magenta Acres, Inc., which now holds approximately 54% of the company's common stock. Subsequently, Chen Zu De was appointed as the Chief Executive Officer and Chairman of the Board.
- Future Outlook: The company anticipates requiring additional capital to meet long-term operating requirements. Management plans to raise additional funds through equity or debt securities to support operational growth.
- Going Concern: There is substantial doubt about the company's ability to continue as a going concern due to its accumulated deficit and lack of stable revenue sources. Management is actively seeking additional investment capital to fund ongoing expenses.
- Impact of COVID-19: The COVID-19 pandemic has introduced uncertainties that could impact the company's operations. While the exact effects are unknown, management expects some degree of impact on business activities.
- Convertible Notes: The company has entered into several convertible note agreements with third parties, which provide potential future conversion into common stock. These notes are part of the company's strategy to secure financing for operational needs.
SEC Filing: